scholarly journals An update on the prevalence of eating disorders in the general population: a systematic review and meta-analysis

2021 ◽  
Author(s):  
Jie Qian ◽  
Ying Wu ◽  
Fanxiao Liu ◽  
Yikang Zhu ◽  
Hua Jin ◽  
...  
Keyword(s):  
Systematic Review ◽  
Eating Disorders ◽  
General Population ◽  
Diagnostic Criteria ◽  
Meta Analysis ◽  
Lifetime Prevalence ◽  
Level Of Evidence ◽  
Prevalence Studies ◽  
Western Countries ◽  
Epidemiological Surveys

Abstract Objective To update the prevalence of eating disorders in the general population before 2021 and to analyze the distribution characteristics at different times and in different regions and sexes, as well as the diagnostic criteria. Methods Based on the method from a previous report by the authors, studies were identified from the following databases: PubMed/Medline, PsycINFO, ISI Web of Knowledge, Ovid and the 4 most important Chinese databases. Articles in English and Chinese before 2021 were retrieved. The data retrieved at this time were pooled with the data from a previous report for analyses. Results Thirty-three studies were identified, which included 18 studies supplemented in this retrieval. The pooled lifetime and 12-month prevalence of eating disorders were 0.91% (95% CI, 0.48–1.71) and 0.43% (95% CI, 0.18–0.78), respectively. The pooled lifetime and 12-month prevalence of the subgroup EDs (any), which covers all types of eating disorders, were 1.69% and 0.72%, respectively. The lifetime prevalence of AN, BN and BED was 0.16% (95% CI, 0.06–0.31), 0.63% (95% CI, 0.33–1.02) and 1.53% (95% CI, 1.00–2.17), respectively. The lifetime prevalence of EDs in Western countries was 1.89%, and was high at 2.58% in females. Prevalence studies using DSM-5 criteria were scarce. Conclusions The prevalence of eating disorders might be underestimated thus far. Not all types of EDs were included in a majority of epidemiological surveys, and the prevalence rates of the new types of EDs were significantly higher. Eating disorders were especially common in Western countries and in females. New diagnostic criteria should be used to comprehensively assess all types of eating disorders. Level of evidence 1, systematic review and meta-analysis.

scholarly journals Incidence of sudden cardiac death in the young: a systematic review

BMJ Open ◽  
2020 ◽  
Vol 10 (10) ◽  
pp. e040815
Author(s):  
Keith Couper ◽  
Oliver Putt ◽  
Richard Field ◽  
Kurtis Poole ◽  
William Bradlow ◽  
...  
Keyword(s):  
Systematic Review ◽  
Sudden Cardiac Death ◽  
General Population ◽  
Cardiac Death ◽  
Data Extraction ◽  
Meta Analysis ◽  
Cochrane Library ◽  
Older Individuals ◽  
Eligibility Criteria ◽  
Prevalence Studies

ObjectiveTo summarise studies describing incidence of sudden cardiac death in a general population of young individuals to inform screening policy.DesignSystematic review.Data sourcesDatabase searches of MEDLINE, EMBASE and the Cochrane library (all inception to current) on 29 April 2019 (updated 16 November 2019), and forward/backward citation tracking of eligible studies.Study eligibility criteriaAll studies that reported incidence of sudden cardiac death in young individuals (12–39 years) in a general population, with no restriction on language or date. Planned subgroups were incidence by age, sex, race and athletic status (including military personnel).Data extractionTwo reviewers independently assessed study eligibility, extracted study data and assessed risk of bias using the Joanna Briggs Institute critical appraisal checklist for prevalence studies.AnalysisReported incidence of sudden cardiac death in the young per 100 000 person-years.Results38 studies that reported incidence across five continents. We identified substantial heterogeneity in population, sudden cardiac death definition, and case ascertainment methods, precluding meta-analysis. Median reported follow-up years was 6.97 million (IQR 2.34 million–23.70 million) and number of sudden cardiac death cases was 64 (IQR 40–251). In the general population, the median of reported incidence was 1.7 sudden cardiac death per 100 000 person-years (IQR 1.3–2.6, range 0.75–11.9). Most studies (n=14, 54%) reported an incidence between one and two cases per 100 000 person-years. Incidence was higher in males and older individuals.ConclusionsThis systematic review identified variability in the reported incidence of sudden cardiac death in the young across studies. Most studies reported an incidence between one and two cases per 100 000 person-years.PROSPERO registration numberCRD42019120563.

scholarly journals A Systematic Review and Meta-Analysis on the Prevalence of Dupuytren Disease in the General Population of Western Countries

2014 ◽  
Vol 133 (3) ◽  
pp. 593-603 ◽  
Author(s):  
Rosanne Lanting ◽  
Dieuwke C. Broekstra ◽  
Paul M. N. Werker ◽  
Edwin R. van den Heuvel
Keyword(s):  
Systematic Review ◽  
General Population ◽  
Meta Analysis ◽  
Western Countries ◽  
Dupuytren Disease

scholarly journals Prevalence of chronic kidney disease in the general population in Latin America and the Caribbean: Protocol for a systematic review and meta-analysis

2021 ◽  
Author(s):  
Diego A Sequeiros-Buendia ◽  
Camila S Villa-Ato ◽  
Marlies Weiss-Carlini ◽  
Rodrigo M Carrillo-Larco
Keyword(s):  
Systematic Review ◽  
Chronic Kidney Disease ◽  
Latin America ◽  
Kidney Disease ◽  
General Population ◽  
Global Health ◽  
Meta Analysis ◽  
Prevalence Studies ◽  
Prevalence Estimates ◽  
The Caribbean

ABSTRACTBackgroundChronic kidney disease (CKD) is a global health issue with a general prevalence of 9%. Although the most affected populations are in low- and middle-income countries, the epidemiology of CKD in these countries remains poorly understood and prevalence estimates come from global efforts informed by data from high-income countries; these prevalence estimates need to be compared –and if needed updated–with local estimates.ObjectiveTo estimate the prevalence of CKD in adults in Latin America and the Caribbean (LAC).MethodsSystematic review and meta-analysis. We will search Embase, Medline, Global Health (these three through Ovid), Scopus and LILACS. No date or language restrictions will be set. We seek observational studies with a random sample of the general population. We will screen titles and abstracts, we will then study the selected reports. Both phases will be done by two reviewers independently. Data extraction will be performed by two researchers independently using a pre-specified Excel form. We will evaluate the risk of bias with the scale proposed by Hoy et al. for prevalence studies. We will conduct a meta-analysis of prevalence estimates, if there are at least three reports homogeneous enough to be pooled; we will use a random-effects model.ConclusionsThis systematic review and meta-analysis will provide the prevalence of CKD in adults in countries of LAC. Currently, information regarding CKD in the region is limited. This work will provide evidence to elucidate the magnitude of CKD prevalence in LAC. In so doing, we will provide evidence to inform the scientific community about the burden of CKD in LAC so that research, policies and health interventions can be planned accordingly.

scholarly journals Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
W. Bai ◽  
Z. H. Liu ◽  
Y. Y. Jiang ◽  
Q. E. Zhang ◽  
W. W. Rao ◽  
...  
Keyword(s):  
Systematic Review ◽  
Suicidal Ideation ◽  
Meta Analysis ◽  
Premature Mortality ◽  
Point Prevalence ◽  
Lifetime Prevalence ◽  
Assessment Scores ◽  
Effective Interventions ◽  
Epidemiological Surveys ◽  
Suicide Plan

AbstractSchizophrenia is a severe psychiatric disorder with high premature mortality rates. This is a meta-analysis and systematic review of the prevalence of suicidal ideation (SI) and suicide plan (SP) among people with schizophrenia. PubMed, Web of Science, Embase, and PsycINFO were systematically searched from their respective inception to October 10, 2020. Data on prevalence of SI and/or SP were synthesized using the random effects model. Twenty-six studies covering 5079 people with schizophrenia were included for meta-analysis. The lifetime and point prevalence of SI were 34.5% (95% CI: 28.2−40.9%), and 29.9% (95% CI: 24.2−35.6%), respectively. The lifetime prevalence of SP was 44.3% and the point prevalence of SP ranged between 6.4 and 13%. Subgroup and meta-regression analyses revealed that source of patients, survey countries, and sample size were significantly associated with the point prevalence of SI, while male proportion and quality assessment scores were significantly associated with the lifetime and point prevalence of SI. Survey time and mean age were significantly associated with lifetime prevalence of SI. Both SI and SP are common in people living with schizophrenia, especially in males and inpatients. Routine screening and effective interventions for SI and SP should be implemented in this population.

scholarly journals Global prevalence of asthma-COPD overlap (ACO) in the general population: a systematic review and meta-analysis

2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Mostafa Hosseini ◽  
Amir Almasi-Hashiani ◽  
Mahdi Sepidarkish ◽  
Saman Maroufizadeh
Keyword(s):  
Systematic Review ◽  
General Population ◽  
Diagnostic Criteria ◽  
Random Effects ◽  
English Language ◽  
Meta Analysis ◽  
Population Based ◽  
Eligibility Criteria ◽  
Global Prevalence ◽  
Pooled Prevalence

Abstract Background Asthma-COPD overlap (ACO) is a term that encompasses patients with features of both asthma and COPD. To date, the global prevalence of ACO in the general population remains unknown. The objective of this study was to estimate the prevalence of ACO in the general population using a systematic review and meta-analysis. Methods A systematic search of ISI Web of Knowledge, MEDLINE/PubMed, and Scopus was performed up to May 2019 to identify studies reporting the prevalence of ACO. Reference lists from identified studies and relevant review articles were also searched. Eligibility criteria were studies reporting the prevalence of ACO, performed in general population, and published in English language. Pooled prevalence of ACO with 95% confidence interval (CI) was calculated using random effects Meta-analysis. Results A total of 27 studies were included in this meta-analysis. The Cochran Q test and I2 statistics revealed substantial heterogeneity among studies. Based on the random-effects model, the pooled prevalence of ACO was 2.0% (95% CI: 1.4–2.6%) in the general population, 26.5% (95% CI: 19.5–33.6%) among patients with asthma, and 29.6% (95% CI: 19.3–39.9%) among patients with COPD. In addition, for included studies, the global prevalence of asthma-only was 6.2% (95% CI: 5.0–7.4%) and COPD-only was 4.9% (95% CI: 4.3–5.5%). Conclusion We estimated the global prevalence of ACO based on population-based studies and found that 2.0% of the general population is affected. However, the prevalence of ACO depends on its diagnostic criteria. Therefore, there is a vital need to better define the ACO diagnostic criteria, management and treatment. It is worth noting that the limitations of the present study include lack of studies in some region of the world and small number of studies included in the subgroup analyses.

scholarly journals Compulsory treatments in eating disorders: a systematic review and meta-analysis

2020 ◽  
Author(s):  
Anna Rita Atti ◽  
Tomas Mastellari ◽  
Stefano Valente ◽  
Maurizio Speciani ◽  
Fabio Panariello ◽  
...  
Keyword(s):  
Systematic Review ◽  
Eating Disorders ◽  
Average Length ◽  
Meta Analysis ◽  
Significant Risk ◽  
Risk Difference ◽  
Level Of Evidence ◽  
Feeding And Eating Disorders ◽  
Baseline Characteristics ◽  
Level I

Abstract Introduction The aims of this systematic review and meta-analysis are to provide a summary of the current literature concerning compulsory treatments in patients with eating disorders (ED) and to understand whether compulsorily and involuntarily treated patients differ in terms of baseline characteristics and treatment outcomes. Methods Relevant articles were identified following the PRISMA guidelines by searching the following terms: “treatment refusal”, “forced feeding”, “compulsory/coercive/involuntary/forced treatment/admission”, “eating disorders”, “feeding and eating disorders”, “anorexia nervosa”, “bulimia nervosa”. Research was restricted to articles concerning humans and published between 1975 and 2020 in English. Results Out of 905 articles retrieved, nine were included for the analyses allowing the comparisons between 242 compulsorily and 738 voluntarily treated patients. Mean body mass index (BMI) was slightly lower in patients compelled to treatments. Mean illness duration, BMI at discharge and BMI variation showed no significant differences between the two groups. Average length of hospitalization was 3 weeks longer among compulsory-treated patients, but this did not result in a higher increase in BMI. No significant risk difference on mortality was estimated (three studies). Conclusions Compulsory treatments are usually intended for patients having worse baseline conditions than voluntary ones. Those patients are unlikely to engage in treatments without being compelled but, after the treatments, albeit with longer hospitalisations, they do achieve similar outcomes. Therefore, we can conclude that forcing patients to treatment is a conceivable option. Level of evidence Level I, systematic review and meta-analysis.

Sign in / Sign up

Export Citation Format

Share Document